Our verdict is Pathogenic. Variant got 10 ACMG points: 10P and 0B. PM1PM2PP2PP3_StrongPP5
The NM_001368894.2(PAX6):c.244C>T(p.Pro82Ser) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 13/21 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Pathogenic (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P82L) has been classified as Uncertain significance.
PAX6 (HGNC:8620): (paired box 6) This gene encodes paired box protein Pax-6, one of many human homologs of the Drosophila melanogaster gene prd. In addition to a conserved paired box domain, a hallmark feature of this gene family, the encoded protein also contains a homeobox domain. Both domains are known to bind DNA and function as regulators of gene transcription. Activity of this protein is key in the development of neural tissues, particularly the eye. This gene is regulated by multiple enhancers located up to hundreds of kilobases distant from this locus. Mutations in this gene or in the enhancer regions can cause ocular disorders such as aniridia and Peter's anomaly. Use of alternate promoters and alternative splicing results in multiple transcript variants encoding different isoforms. Interestingly, inclusion of a particular alternate coding exon has been shown to increase the length of the paired box domain and alter its DNA binding specificity. Consequently, isoforms that carry the shorter paired box domain regulate a different set of genes compared to the isoforms carrying the longer paired box domain. [provided by RefSeq, Mar 2019]
Verdict is Pathogenic. Variant got 10 ACMG points.
PM1
?
PM1 - Located in a mutational hot spot and/or critical and well-established functional domain (e.g., active site of an enzyme) without benign variation
In a hotspot region, there are 6 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 0 benign, 3 uncertain in NM_001368894.2
PM2
?
PM2 - Absent from controls (or at extremely low frequency if recessive) in Exome Sequencing Project, 1000 Genomes Project, or Exome Aggregation Consortium
Very rare variant in population databases, with high coverage;
PP2
?
PP2 - Missense variant in a gene that has a low rate of benign missense variation and in which missense variants are a common mechanism of disease
Missense variant where missense usually causes diseases, PAX6
PP3
?
PP3 - Multiple lines of computational evidence support a deleterious effect on the gene or gene product (conservation, evolutionary, splicing impact, etc.)
MetaRNN computational evidence supports a deleterious effect, 0.991
PP5
?
PP5 - Reputable source recently reports variant as pathogenic, but the evidence is not available to the laboratory to perform an independent evaluation
Variant 11-31801716-G-A is Pathogenic according to our data. Variant chr11-31801716-G-A is described in ClinVar as [Pathogenic]. Clinvar id is 3475.Status of the report is no_assertion_criteria_provided, 0 stars.
.;.;.;Gain of phosphorylation at P68 (P = 0.0254);Gain of phosphorylation at P68 (P = 0.0254);Gain of phosphorylation at P68 (P = 0.0254);Gain of phosphorylation at P68 (P = 0.0254);Gain of phosphorylation at P68 (P = 0.0254);.;Gain of phosphorylation at P68 (P = 0.0254);.;.;.;.;.;Gain of phosphorylation at P68 (P = 0.0254);Gain of phosphorylation at P68 (P = 0.0254);.;Gain of phosphorylation at P68 (P = 0.0254);Gain of phosphorylation at P68 (P = 0.0254);.;Gain of phosphorylation at P68 (P = 0.0254);Gain of phosphorylation at P68 (P = 0.0254);Gain of phosphorylation at P68 (P = 0.0254);Gain of phosphorylation at P68 (P = 0.0254);.;Gain of phosphorylation at P68 (P = 0.0254);.;.;.;